Table 2

Efficacy endpoints of the different therapy groups

BS group
(n=81)
AG group
(n=39)
AS group
(n=38)
Total
(n=158)
p Value
Primary endpoints
 Successful PTAS (n (%))79 (97.5)35 (89.7)38 (100.0)152 (96.2)0.042
Secondary endpoints
 Any stroke or death4 (4.9)0 (0.0)3 (7.9)7 (4.4)0.231
  Any ischemic stroke4 (4.9)0 (0.0)2 (5.3)6 (3.8)0.359
  Any hemorrhagic stroke0 (0.0)0 (0.0)1 (2.4)1 (0.6)0.204
  Death0 (0.0)0 (0.0)0 (0.0)0 (0.0)
 MI0 (0.0)0 (0.0)0 (0.0)0 (0.0)
 SAE0 (0.0)0 (0.0)1 (2.4)0 (0.6)0.204
 mRS≥32 (2.5)0 (0.0)2 (5.3)4 (2.5)0.339
  • AG group, angioplasty group; AS group, angioplasty plus self-expanding stent group; BS group, balloon mounted stent group; MI, myocardial infarction; mRS, modified Rankin Scale; PTAS, percutaneous transluminal angioplasty and stenting; SAE, serious adverse event.